FOSCARNET SODIUM
Active substance: foscarnet
INJECTION, SOLUTION · FOSCARNET SODIUM 6000 mg/250mL
United StatesActive
Marketing holder: Baxter Healthcare Corporation
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- FOSCARNET SODIUM · 6000 mg/250mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-4cf8-747c-bdb5-19792c96355c,01a1208c-5c26-702b-8fed-922c00e71e97,01a1208d-c38f-73a4-979e-2a2ea24c05c7,01a1208f-a276-7987-983a-ad27bb023769,01a12091-75d2-7aab-8521-7c3d36eae5d2;count=10 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 43066-089
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 43066-089 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 43066-089 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 43066-089 · Verified 2026-10-09 · open in source